Medscape Poll: Antiamyloid Therapy in Alzheimer's Disease
Antiamyloid medications like lecanemab and donanemab can modestly slow cognitive decline in Alzheimer's disease, but clinicians remain divided on whether the benefits are meaningful enough and which patients may benefit most. Medscape Reader Polls
Original Source
Read the full article at Medscape →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.